A long DMR (between 18 and 22 differentially methylated CpGs, depending on the dataset analyzed) covering the first exon of SLFN12 showed hypermethylation in MS patients compared to healthy controls in both CD4+ and CD8+ T cells (Fig 2). This evidence concerns the gene SLFN12 and myeloid sarcoma.